University Teaching Hospital Hall in Tirol Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2009
NCT00820352
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

University Teaching Hospital Hall i.T.

Active Ingredients

Drugs in Phase 3 Trials (1)

bosentan (tracleer) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Failure (Phase 3)

Heart Failure, Diastolic (Phase 3)

Hypertension (Phase 3)

Hypertension, Pulmonary (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1